Abstract
The assessment of the proliferation fraction is becoming more and more important; however, there is no consensus concerning optimal validation. Depending on the institute the proliferation fraction is determined either from a core biopsy (SB) or resection specimen (OP). The interobserver variability and the results of SB and OP were investigated whereby two pathologists independently estimated the proliferation fraction of 90 cases of invasive breast cancer. The results (Ki-67) were quantified, categorized, and compared. Identical (accuracy of 5% steps) results between the 2 pathologists were achieved in 43% (n=39) for SB, 47% (n=42) for OP and 60% (n=54) for SB versus OP. When categorizing the proliferation fraction (low ≤ 15%, moderate 20-30% and high ≥ 35%) the following results were achieved: 76% (n=68) for SB, 82% (n=74) for OP and 81% (n=73) for SB versus OP. There was a clear interobserver variability (SB: kappa=0.32, OP: kappa=0.34) but this could be dramatically improved by forming proliferation categories (SB: kappa=0.62, OP: kappa=0.72, 60 versus 81%). In SB with a low proliferation fraction a repeated analysis in OPs can be advisable as a higher proliferation fraction is observed in up to 12% of OPs.
References
Jan 15, 1983·International Journal of Cancer. Journal International Du Cancer·J GerdesH Stein
Nov 17, 2001·British Journal of Cancer·A BottiniL Dogliotti
Dec 18, 2001·Cancer·D M GrzybickiS S Raab
Oct 11, 2002·The Journal of Pathology·Michael MengelHans Kreipe
Nov 13, 2004·Applied Immunohistochemistry & Molecular Morphology : AIMM·Suash SharmaRaheela Ashfaq
Jan 11, 2005·Cancer Letters·Antonio CavaliereEmilio Bucciarelli
Feb 8, 2005·The Breast : Official Journal of the European Society of Mastology·C BadoualP Michenet
Apr 25, 2007·British Journal of Cancer·E de AzambujaM Paesmans
Jan 1, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A NeriF Roviello
Nov 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe VialeUNKNOWN Breast International Group Trial 1-98
May 14, 2009·Breast Cancer Research : BCR·Catherine OakmanAngelo Di Leo
Jun 19, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Sep 5, 2009·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Reiki NishimuraNobuyuki Arima
Feb 16, 2010·The Lancet Oncology·Rinat YerushalmiKaren A Gelmon
Jul 14, 2010·Breast Cancer Research and Treatment·Mohammed A AleskandaranyAndrew R Green
Jul 29, 2010·Breast Cancer Research : BCR·Vilppu J TuominenJorma Isola
Sep 16, 2010·Journal of Cancer·Yi-Hsuan HsiaoYan-Gao Man
Feb 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MalvezziE Negri
Oct 1, 2011·Journal of the National Cancer Institute·Mitch DowsettUNKNOWN International Ki-67 in Breast Cancer Working Group
Citations
Jul 7, 2014·Carcinogenesis·Christian F SingerErnst Kubista
Apr 18, 2015·PloS One·Zsuzsanna VargaThomas Ruhstaller
Sep 21, 2019·Scientific Reports·Zsuzsanna VargaThomas Ruhstaller